alpha1-acid glycoprotein in late-life depression: relationship to medical burden and genetics.

MLA

Adeoye, Opeolu M., et al. “Alpha1-Acid Glycoprotein in Late-Life Depression: Relationship to Medical Burden and Genetics.” Journal of Geriatric Psychiatry and Neurology, vol. 16, no. 4, Dec. 2003, pp. 235–39. EBSCOhost, https://doi.org/10.1177/0891988703258321.

APA

Adeoye, O. M., Ferrell, R. E., Kirshner, M. A., Mulsant, B. H., Seligman, K., Begley, A. E., Reynolds, C. F., 3rd, & Pollock, B. G. (2003). alpha1-acid glycoprotein in late-life depression: relationship to medical burden and genetics. Journal of Geriatric Psychiatry and Neurology, 16(4), 235–239. https://doi.org/10.1177/0891988703258321

Chicago

Adeoye, Opeolu M, Robert E Ferrell, Margaret A Kirshner, Benoit H Mulsant, Karen Seligman, Amy E Begley, Charles F Reynolds 3rd, and Bruce G Pollock. 2003. “Alpha1-Acid Glycoprotein in Late-Life Depression: Relationship to Medical Burden and Genetics.” Journal of Geriatric Psychiatry and Neurology 16 (4): 235–39. doi:10.1177/0891988703258321.